Bed Bath & Beyond (BBBY) Misses Q4 EPS by 95c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Goldman Sachs on Bed Bath & Beyond (BBBY): 'sizable miss to our expectations', Says of Co Bonds 'We expect the market reaction to be quite negative'
April 13, 2022 8:58 AM EDTGoldman Sachs analyst Kate McShane reiterated a Sell rating and $14.00 price target on Bed Bath & Beyond (NASDAQ: BBBY).
The analyst comments "BBBY reported 4Q21 adj. EPS of ($0.92), much below Consensus (Reuters) of $0.03, with a comp decline of 12%, vs GS/ Consensus estimates of -8%/-9%. The Bed, Bath & Beyond banner witnessed a comp decline of 15%, while there was growth of low single digits for the buybuy Baby banner compared to mid teen growth for the banner in 3Q21.... More
